MarketPeel
MW

Markus Warmuth

GLUE
PRESIDENT & CEO · MONTE ROSA THERAPEUTICS, INC. · CIK 0001855643
FILING MIX · LIFETIME47%/53%
BUYS
9
SELLS
10
TOTAL VALUE
$951.1K
COMPANIES
1
ACTIVE SINCE
Apr 2021
HOLDINGS NOW
585,038
AVG SELL PX
$19.21
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 17 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Markus Warmuth, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+14.29%+13.25%+0.57%+12.68%+3.24%
14d7+28.57%+11.22%-0.05%+11.27%+4.69%
30d7+57.14%-1.12%+0.43%-2.54%-9.41%
60d7+57.14%-4.66%+1.07%-5.73%-10.81%
90d7+42.86%-0.91%-1.24%-0.91%-3.02%
180d7(3 pending)+0.00%+20.03%+8.08%+11.95%-4.01%
1y7(7 pending)
2y7(7 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GLUE · 585,038 shares · as of Jul 16, 2026
0158,635317,269475,904634,53820222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 9 buys / 10 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
President & CEO
9,500$23.18$220.2K585,038Jul 16, 2026Jul 17, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,998$19.41$97.0K595,006Jun 1, 2026Jun 2, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
468$19.73$9.2K594,538Jun 1, 2026Jun 2, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,467$18.92$103.4K600,004May 1, 2026May 5, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
President & CEO
8,000$17.64$141.1K605,471Apr 14, 2026Apr 15, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,466$17.92$98.0K613,471Mar 2, 2026Mar 4, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,707$23.24$86.2K620,696Jan 7, 2026Jan 9, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
309$24.57$7.6K618,937Jan 7, 2026Jan 9, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,450$23.88$34.6K619,246Jan 7, 2026Jan 9, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
SALE
President & CEO
10,135$15.17$153.7K624,403Jan 5, 2026Jan 5, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
406,000406,000Jan 2, 2026Jan 5, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
90,000634,538Jan 2, 2026Jan 5, 2026View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
128,000544,538Jan 2, 2025Jan 6, 2025View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
575,000575,000Jan 2, 2025Jan 6, 2025View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
346,000346,000Jan 2, 2024Jan 4, 2024View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
472,000472,000Jan 3, 2023Jan 4, 2023View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
315,600315,600Mar 1, 2022Mar 2, 2022View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
141,623141,623Jun 23, 2021Jun 25, 2021View →
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
538,517538,517Apr 12, 2021Jun 25, 2021View →
Other insiders · GLUE
Loading peer insiders…
About this filer
CIK 0001855643
ROLE
President & CEO
PRIMARY
GLUE
COMPANIES
1
ACTIVE SINCE
Apr 2021
MARKETPEEL · /INSIDER/0001855643DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback